|
|
 |
JOSEPH FRANCIS MURPHY, PH. D. PARTNER TELEPHONE: 215-567-2010.
EXTENSION
FAX: 215-751-1142
jmurphy@crbcp.com
|
 
Dr. Murphy is a registered Patent Attorney and practices all aspects of patent prosecution, including patent reissue and reexamination proceedings. He has extensive experience in the prosecution of Inter Partes Reexaminations, and prosecution before the Board of Patent Appeals and Interferences. Dr. Murphy's practice also includes international patent prosecution and opinion work, including validity, invalidity, infringement and freedom to operate. He in experienced in diversified technologies, especially in the biotechnological, chemical, and pharmaceutical arts. Prior to joining the firm, Dr. Murphy worked for 6 years in the United States Patent and Traemark Office as a Biotechnology Patent Examiner. He has Full Signatory Authority and was a Master's Level Examiner. He was reponsible for examining patents involving cytokines, chemokines, G protien-coupled receptors, Ion channels, and other polypeptides. Dr. Murphy received his Ph.D. in Physiology from the University of Virginia in 1997. He did his post-doctoral fellowship at the A.I. DuPont Institute in the Epithelial Cell Biology Laboratory from 1997-1999. He served as a Post Doctoral Scientist for Message Pharmaceuticals, Inc. developing assays for secondary screening of compunds that target RNA. A graduate of George Washington University School of Law (2005), Dr. Murphy received his undergraduate degree in Biology from St. Joseph' University in 1989.
Tibotec, Searle v. Hetero Drugs Ltd. (D. N.J. 2011) represented generic in ANDA litigation on Prezista® (darunavir)
Orexo AB v. Edict Pharmaceuticals Ltd. (D. N.J. 2011) represented generic in ANDA litigation on Zolpidem® sublingual (zolpidem tartrate)
Teva Pharmaceutical Industries, Ltd. v. Hetero Drugs, Ltd. (D. Md. 2007), represented generic manufacturer in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)
Teva Pharmaceutical Industries, Ltd. v. Apotex, Inc. (D. N.J. 2007) represented ANDA applicant in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)
Teva Pharmaceutical Industries, Ltd. v. Apotex, Inc. (D. Md. 2007) represented ANDA applicant in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)
Pennsylvania
U.S Patent and Trademark Office
U.S. Court of Appeals for the Federal Circuit
St. Joseph's University: B.S. Biology
University of Virginia: Ph. D. Physiology
George Washington University Law School: J.D.
RETURN TO TOP OF PAGE
|
|
JOSEPH FRANCIS MURPHY, PH. D. PARTNER
INDUSTRIES SERVED
Biotechnology
Biology
Educational and Research Institutions
Pharmaceutical
ADMITTED TO PRACTICE
Pennsylvania
U.S. Patent and Trademark Office
U.S. Court of Appealfs for the Federal Circuit
EDUCATIONAL
BACKGROUND
St. Joseph's University: B.S. Biology
University of Virginia : Ph. D. Physiology
George Washington University Law School: J.D.
|
|
